Publications en collaboration avec des chercheurs de Complexo Hospitalario Universitario de Santiago (18)

2024

  1. Genetic linkage analysis of head and neck cancer in a Spanish family

    Oral Diseases, Vol. 30, Núm. 3, pp. 1032-1039

2021

  1. Immunoexpression of Apoptosis and Cell-cycle Arrest Markers in Oral Lichen Planus

    Applied immunohistochemistry & molecular morphology : AIMM, Vol. 29, Núm. 5, pp. 374-381

  2. Immunohistochemical Characterization of Bcl-2 in Oral Potentially Malignant Disorders

    Applied Immunohistochemistry and Molecular Morphology, Vol. 29, Núm. 9, pp. 706-712

2020

  1. Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population

    ecancermedicalscience, Vol. 14

2019

  1. Comprehensive genomic review of TCGA head and neck squamous cell carcinomas (HNSCC)

    Journal of Clinical Medicine, Vol. 8, Núm. 11

  2. miRNAs expression of oral squamous cell carcinoma patients: Validation of two putative biomarkers

    Medicine, Vol. 98, Núm. 13, pp. e14922

2018

  1. Dental management prior to radiation therapy in patients with head and neck cancer

    Indian Journal of Cancer, Vol. 55, Núm. 3, pp. 251-256

  2. Quality variations of extractable RNA in frozen samples of oral cancer (21 y); optimization of the extraction protocol

    Biomedical Research (India), Vol. 29, Núm. 12, pp. 2522-2527

  3. State of methylation and epigenome studies in some types of head and neck cancer

    Biomedical Research (India), Vol. 29, Núm. 14, pp. 2944-2955

2016

  1. Comparison of rna extraction methods for molecular analysis of oral cytology

    Acta Stomatologica Croatica, Vol. 50, Núm. 2, pp. 108-115

  2. HIN-1: a New Epigenetic Biomarker Crucial for Therapy Selection in Glioblastoma Multiforme

    Molecular Neurobiology, Vol. 53, Núm. 3, pp. 1802-1807

2015

  1. Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction

    Clinical and Translational Oncology, Vol. 17, Núm. 11, pp. 856-861

  2. P21Waf1/CIP1 is a poor diagnostic and prognostic marker for OSCC although its expression increases in patients with N1 regional metastasis

    Cancer Biomarkers, Vol. 15, Núm. 1, pp. 19-26

2014

  1. CA15.3 serum concentrations in older women with infiltrating ductal carcinomas of the breast

    International Journal of Molecular Sciences, Vol. 15, Núm. 11, pp. 19870-19876

  2. Pancreatic ductal adenocarcinoma: Implications of epigenetic role related the src pathway

    Journal of Cancer Science and Therapy, Vol. 6, Núm. 2, pp. 045-051

  3. Quantitative determination of c-myc facilitates the assessment of prognosis of OSCC patients

    Oncology Reports, Vol. 31, Núm. 4, pp. 1677-1682

2013

  1. Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer

    Oncology Reports, Vol. 29, Núm. 6, pp. 2467-2472

2012

  1. Stem cells as a tool for breast imaging

    Journal of Oncology